Previous close | 32.46 |
Open | 32.50 |
Bid | 32.31 x 13000 |
Ask | 32.62 x 12700 |
Day's range | 32.25 - 32.50 |
52-week range | 29.45 - 44.20 |
Volume | |
Avg. volume | 35 |
Market cap | 16.434B |
Beta (5Y monthly) | 0.64 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.08 (3.32%) |
Ex-dividend date | 31 May 2024 |
1y target est | N/A |
Baxter's (BAX) receipt of the latest expanded indication for Clinolipid is expected to meet the diverse nutritional needs of patients, ranging from preterm neonates to adults.
Baxter International Inc. ( NYSE:BAX ) will pay a dividend of $0.29 on the 1st of July. This means the annual payment...
Baxter International ( NYSE:BAX ) First Quarter 2024 Results Key Financial Results Revenue: US$3.59b (up 2.2% from 1Q...